no statement of use filed
on 07 Sep 2020
Last Applicant/ Owned by
Trademark Operations - MS-28-5A
Thousand Oaks
CA
913201799
Serial Number
87146623 filed on 22nd Aug 2016
Registration Number
N/A
Correspondent Address
Timothy J. Gaul
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
pharmaceutical preparations, biosimilars and pharmaceutical substances used for the treatment of bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, blood cells, blood vessel, and blood diseases and disorders; pharmaceutical preparations, biosimilars and pharmaceutical substances for the treatment of autoimmune, immuRead More
pharmaceutical preparations, biosimilars and pharmaceutical substances used for the treatment of bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, blood cells, blood vessel, and blood diseases and disorders; pharmaceutical preparations, biosimilars and pharmaceutical substances for the treatment of autoimmune, immune system, inflammatory, inflammatory bowel, gastrointestinal, genitourinary, musculoskeletal, dermatological, pulmonary, respiratory, oncological, hepatological, lymphomas, leukemias, ophthalmic, transplant rejection, cardiovascular, endocrine, neurological, sleep, muscular, and psychiatric diseases and disorders; pharmaceutical preparations and biosimilars, namely, pharmaceutical preparations and pharmaceutical substances used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, polymyalgia rheumatic, spondyloarthropathies, acute disc prolapse, inflammatory bowel disease, Crohn's disease, ulcerative colitis, Intestinal Behçet's Disease, chronic pouchitis, small bowel lesions, Hermansky-Pudlak syndrome, autoimmune pancreatitis, multiple myeloma, multiple sclerosis, systemic lupus erythematosus, lupus nephritis, chronic inflammatory demyelinating polyneuropathy, autoimmune anemia, autoimmune hemolytic anemia, pure red cell aplasia, idiopathic thrombocytopenic purpura, Evans syndrome, type 1 diabetes mellitus, Sjogren's syndrome, encephalitis, IgG4-related disease, Devic's disease, myositis, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, palmoplantar psoriasis, hidradenitis suppurativa, bullous skin disorder, pemphigus, pemphigoid, kawasaki disease, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, age-related macular degeneration, refractory diabetic macular edema, uveitis, childhood uveitis, uveitic macular edema, choroidal neovascularization, Graves' ophthalmopathy, pyoderma gangrenosum, giant cell arteritis, Netherton syndrome, anaplastic thyroid cancer, breast cancer, ovarian cancer, cervical cancer, gastric cancer, colorectal cancer, non-squamous non-small cell lung cancer, glioblastoma, renal cell carcinoma, head and neck cancer, Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, lymphocyte predominant subtype of Hodgkin's Lymphoma, vasculitis, granulomatosis with polyangiitis, microscopic polyangiitis, graft-versus-host disease, graft-versus-host disease following allogenic hematopoietic stem cell transplantation, graft-versus-host disease following keratoprosthesis, kidney transplant, asthma, chronic fatigue syndrome, major depression, and bipolar depression
No 87146623
No Service/Collective Mark
No TM-1479-US-1
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
08th Sep 2020 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
07th Sep 2020 | ABANDONMENT - NO USE STATEMENT FILED |
23rd Nov 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
22nd Nov 2019 | EXTENSION 5 GRANTED |
22nd Nov 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
20th Nov 2019 | TEAS EXTENSION RECEIVED |
20th Nov 2019 | EXTENSION 5 FILED |
28th May 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
24th May 2019 | TEAS EXTENSION RECEIVED |
24th May 2019 | EXTENSION 4 FILED |